SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hultberg A) "

Sökning: WFRF:(Hultberg A)

  • Resultat 1-10 av 26
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Clarke, Robert, et al. (författare)
  • Lowering blood homocysteine with folic acid based supplements : Meta-analysis of randomised trials
  • 1998
  • Ingår i: British Medical Journal. - : BMJ. - 0959-8146. ; 316:7135, s. 894-898
  • Forskningsöversikt (refereegranskat)abstract
    • Objective: To determine the size of reduction in homocysteine concentrations produced by dietary supplementation with folic acid and with vitamins B-12 or B-6. Design: Meta-analysis of randomised controlled trials that assessed the effects of folic acid based supplements on blood homocysteine concentration. Multivariate regression analysis was used to determine the effects on homocysteine concentrations of different doses of folic acid and of the addition of vitamin B-12 or B-6. Subjects: Individual data on 1114 people included in 12 trials. Findings: The proportional and absolute reductions in blood homocysteine produced by folic acid supplements were greater at higher pretreatment blood homocysteine concentrations (P < 0.001) and at lower pretreatment blood folate concentrations (P < 0.001). After standardisation to pretreatment blood concentrations of homocysteine of 12 μmol/l and of folate of 12 nmol/l (approximate average concentrations for Western populations), dietary folic acid reduced blood homocysteine concentrations by 25% (95% confidence interval 23% to 28%; P < 0.001), with similar effects in the range of 0.5-5 mg folic acid daily. Vitamin B-12 (mean 0.5 mg daily) produced an additional 7% (3% to 10%) reduction in blood homocysteine. Vitamin B-6 (mean 16.5 mg daily) did not have a significant additional effect. Conclusions: Typically in Western populations, daily supplementation with both 0.5-5 mg folic acid and about 0.5 mg vitamin B-12 would be expected to reduce blood homocysteine concentrations by about a quarter to a third (for example, from about 12 μmol/l to 8-9 μmol/l). Large scale randomised trials of such regimens in high risk populations are now needed to determine whether lowering blood homocysteine concentrations reduces the risk of vascular disease.
  •  
2.
  • Abrikosov, Igor A., et al. (författare)
  • Finite Temperature, Magnetic, and Many-Body Effects in Ab Initio Simulations of Alloy Thermodynamics
  • 2013
  • Ingår i: TMS2013 Supplemental Proceedings. - Hoboken, NJ, USA : John Wiley & Sons. - 9781118605813 - 9781118663547 ; , s. 617-626
  • Bokkapitel (refereegranskat)abstract
    • Ab initio electronic structure theory is known as a useful tool for prediction of materials properties. However, majority of simulations still deal with calculations in the framework of density functional theory with local or semi-local functionals carried out at zero temperature. We present new methodological solution.s, which go beyond this approach and explicitly take finite temperature, magnetic, and many-body effects into account. Considering Ti-based alloys, we discuss !imitations of the quasiharmonic approximation for the treatment of lattice vibrations, and present an accurate and easily extendable method to calculate free ,energies of strongly anharmonic solids. We underline the necessity to going beyond the state-of-the-art techniques for the determination of effective cluster interactions in systems exhibiting mctal-to-insulator transition, and describe a unified cluster expansion approach developed for this class of materials. Finally, we outline a first-principles method, disordered local moments molecular dynamics, for calculations of thermodynamic properties of magnetic alloys, like Cr1-x,.AlxN, in their high-temperature paramagnetic state. Our results unambiguously demonstrate importance of finite temperature effects in theoretical calculations ofthermodynamic properties ofmaterials.
  •  
3.
  •  
4.
  • Gustafsson, A., et al. (författare)
  • Carbohydrate-dependent inhibition of Helicobacter pylori colonization using porcine milk
  • 2006
  • Ingår i: Glycobiology. - : Oxford University Press (OUP). - 0959-6658 .- 1460-2423. ; 16:1, s. 1-10
  • Tidskriftsartikel (refereegranskat)abstract
    • Breast milk has a well-known anti-microbial effect, which is in part due to the many different carbohydrate structures expressed. This renders it a position as a potential therapeutic for treatment of infection by different pathogens, thus avoiding the drawbacks of many antibiotics. In a previous study, we showed that pigs express the Helicobacter pylori receptors, sialyl Lewis x (Le x) and Le b, on various milk proteins. Here, we investigate the pig breed- and individual-specific expression of these epitopes, as well as the inhibitory capacity of porcine milk on H. pylori binding and colonization. Milk proteins from three different pig breeds were analysed by western blotting using antibodies with known carbohydrate specificity. An adhesion assay was used to investigate the capacity of pig milk to inhibit H. pylori binding to neoglycoproteins carrying Le b and sialyl-di-Le x. alpha1,3/4-fucosyltransferase transgenic FVB/N mice, known to express Le b and sialyl Le x in their gastric epithelium, were colonized by H. pylori and were subsequently treated with Le b- and sialyl Le x-expressing or nonexpressing porcine milk, or water (control) only. The degree of H. pylori colonization in the different treatment groups was quantified. The expression of the Le b and sialyl Le x carbohydrate epitopes on pig milk proteins was breed- and individual specific and correlated to the ability of porcine milk to inhibit H. pylori adhesion in vitro and H. pylori colonization in vivo. Milk from certain pig breeds may have a therapeutic and/or prophylactic effect on H. pylori infection.
  •  
5.
  •  
6.
  • Selden, A., et al. (författare)
  • Trichloroethylene exposure in vapour degreasing and the urinary excretion of N-acetyl-beta-D-glucosaminidase
  • 1993
  • Ingår i: Archives of Toxicology. - 0340-5761. ; 67:3, s. 224-6
  • Tidskriftsartikel (refereegranskat)abstract
    • In order to elucidate the potential nephrotoxicity of low level occupational exposure to trichloroethylene (TRI), urine analysis of the tubular enzyme N-acetyl-beta-D-glucosaminidase (U-NAG) was included in a cross-sectional study of metal degreasers in central Sweden. Eighty-six percent of 8-h TRI in air measurements were well below 50 mg/m3. Normal levels of NAG were found in morning urine samples from 29 workers compared to a historical reference group. A weak positive correlation (r = 0.48; P < 0.01) was observed between U-NAG activity and the concentration of the TRI metabolite trichloroacetic acid in urine but not with other estimates of recent or long-term exposure. In conclusion, TRI does not seem to be nephrotoxic at low exposure levels.
  •  
7.
  • Agardh, Carl-David, et al. (författare)
  • Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus
  • 1994
  • Ingår i: Scandinavian Journal of Clinical & Laboratory Investigation. - : Informa UK Limited. - 1502-7686 .- 0036-5513. ; 54:8, s. 637-641
  • Tidskriftsartikel (refereegranskat)abstract
    • The reactive vascular-injuring amino acid homocysteine was previously shown to be increased in plasma in diabetic patients with clinical signs of nephropathy. In this study, plasma homocysteine was measured in type 1 diabetic patients with normoalbuminuria (n = 22), microalbuminuria (n = 40) and proteinuria (n = 14) in order to investigate whether plasma homocysteine levels are increased already at the stage of incipient nephropathy, i.e. microalbuminuria. Furthermore, patients were characterized according to the degree of retinopathy. Plasma homocysteine in the whole population (n = 76) was related to B-Folate (r = 0.38, p < 0.01), S-Creatinine (r = 0.55, p < 0.001), S-Urea (r = 0.37, p < 0.01), U-Albumin (r = 0.46, p < 0.001), urinary N-acetyl-beta- glucosaminidase (r = 0.40, p < 0.001), systolic blood pressure (r = 0.36, p < 0.01) and diabetes duration (r = 0.44, p < 0.001). There were no differences in plasma homocysteine levels between patients with normoalbuminuria (8.0 +/- 1.7 mumol l-1; mean +/- SD) and those with microalbuminuria (9.1 +/- 3.4 mumol l-1). However, patients with clinical signs of nephropathy had higher plasma homocysteine levels (12.9 +/- 5.7 mumol l-1, p < 0.01) compared to the other two groups. There was no association between plasma homocysteine levels and different degrees of retinopathy. Thus, the present study does not show any relation between plasma homocysteine levels and early stages of diabetic nephropathy or retinopathy indicating that elevated concentrations of plasma homocysteine does not explain the increased risk for atherosclerosis observed in patients with microalbuminuria.
  •  
8.
  • Alksnis, M., et al. (författare)
  • Use of synthetic oligodeoxyribonucleotides for type-specific identification of coxsackie B viruses
  • 1989
  • Ingår i: Molecular and Cellular Probes. - : Elsevier BV. - 0890-8508 .- 1096-1194. ; 3:2, s. 103-108
  • Tidskriftsartikel (refereegranskat)abstract
    • Synthetic oligodeoxyribonucleotides were used for type-specific identification of members of the coxsackie B virus group by nucleic acid hybridization. Two pairs of oligonucleotide chains were constructed based on nucleotide sequences in the VP1 regions of coxsackieviruses B3 and B4. Each labelled probe had a length of 24 nucleotides. The results showed that the oligonucleotide hybridized in a type-specific manner when assayed with extracts from cells infected with all different coxsackie B viruses. A method based on similar principles may thus be used for enterovirus typing.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 26
Typ av publikation
tidskriftsartikel (21)
konferensbidrag (3)
forskningsöversikt (1)
bokkapitel (1)
Typ av innehåll
refereegranskat (22)
övrigt vetenskapligt/konstnärligt (4)
Författare/redaktör
Hammarstrom, L (9)
Hultberg, B (7)
Marcotte, H (6)
Andersson, A (4)
Kruger, C. (3)
Agardh, Carl-David (2)
visa fler...
Agardh, Elisabet (2)
Hultberg, Björn (2)
Gustafsson, A (2)
Zhao, Y. (1)
Wen, S. (1)
Borén, Thomas (1)
Holgersson, Jan (1)
Larsson, J. (1)
Lindbladh, Matts (1)
Nilsson, I. (1)
Abrikosov, Igor A. (1)
Alling, Björn (1)
Steneteg, Peter (1)
Hultberg, Lasse (1)
Hellman, Olle (1)
Yu Mosyagin, Igor (1)
Lugovskoy, Andrey V. (1)
Barannikova, Svetlan ... (1)
Israelsson, Bodil (1)
Isaksson, Anders (1)
Carlsson, M (1)
Persson, B (1)
Witzell, Johanna (1)
Martín, Juan A (1)
Clarke, Robert (1)
Magnusson, A. (1)
Matthiessen, P. (1)
Gaillard, Marie-Jose (1)
Ahlborg, Gunnar, 194 ... (1)
Carlsson, G. (1)
Medin, E (1)
Wikstrom, A (1)
Rutegård, Jörgen (1)
Hultberg, Malin (1)
Åsberg Johnels, Jako ... (1)
Albrectsen, Benedict ... (1)
Marquer, Laurent (1)
Holgersson, J (1)
Andersen, KK (1)
Alksnis, M. (1)
Lindberg, A Michael (1)
Stålhanske, POK (1)
Hultberg, H. (1)
Pettersson, U. (1)
visa färre...
Lärosäte
Karolinska Institutet (10)
Lunds universitet (9)
Göteborgs universitet (3)
Umeå universitet (3)
Linnéuniversitetet (3)
Linköpings universitet (2)
visa fler...
Sveriges Lantbruksuniversitet (2)
visa färre...
Språk
Engelska (26)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (10)
Naturvetenskap (4)
Teknik (1)
Lantbruksvetenskap (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy